Atreca, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2020-02-11: Study NCT04244552; Company role Lead sponsor; Phase Phase 1; Status Terminated.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2020-02-11 | NCT04244552 A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies | Lead sponsor | Phase 1 | Terminated | Breast Cancer; Colorectal Cancer; Ovarian Cancer; Non-Small Cell Lung Cancer; Acral Lentiginous Melanoma; Head and Neck Squamous Cell Carcinoma; Hepatocellular Carcinoma; Esophageal Squamous Cell Carcinoma; Urothelial Carcinoma; DMMR Colorectal Cancer; MSI-H Colorectal Cancer; Melanoma; Platinum-Resistant Primary Peritoneal Carcinoma; Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Epithelial Ovarian Cancer; Triple Negative Breast Cancer | 87 | 2023-11-01 |